Research continues to show that more aggressive surgical treatment is not always better for some breast cancer patients, yet many physicians and patients continue to opt for the maximalist approach. Is change possible?
New research found no difference in rates of preterm births after adjusting for other risk factors.
Researchers claim immunotherapy may offer improved outcomes for patients experiencing HRP ovarian cancer.
New recommendations suggest every woman should be screened, whether or not they bring it up during an exam.
A recent systematic review found that for patients who underwent pelvic organ prolapse (POP) surgery, pain with sex decreased and overall sexual function improved or was unchanged. The results may inform how surgeons discuss POP surgery with patients.
Initial results from the Southwest Oncology Group (SWOG) phase 3 RxPONDER trial demonstrate that postmenopausal women with a common form of breast cancer may be able to forego chemotherapy — and its potential adverse effects — in favor of standalone hormone therapy.
New guidelines on how to treat hereditary breast cancer could be a gamechanger.
Convenience, fewer missed appointments and lower insurance costs benefit patients and doctors. Having access to patients’ medical records, private on-camera communication, and reducing unnecessary in-office and ER visits are a few reasons telemedicine continues to grow in popularity.
Study Suggests Connection Between Ovarian Cancer and Fibrosis, Provides Possible Risk Management Option
A recent study in Ottawa poses a connection between ovarian fibrosis and the risk of developing ovarian cancer, and hints at a drug that may decrease that risk.
Researchers at the University of Washington and four other health institutes explore whether at-home screening tests are an efficient and effective way to detect cervical precancer.
- 1 of 6
- next ›